Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Bortezomib-mediated 26S proteasome inhibition causes cell-cycle arrest and induces apoptosis in CD-30+ anaplastic large cell lymphoma

Leukemia volume 21, pages 838–842 (2007)Cite this article

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

References

  1. Adams J . The proteasome: a suitable antineoplastic target. Nat Rev Cancer 2004; 4: 349–360.

    Article  CAS  Google Scholar 

  2. Boccadoro M, Morgan G, Cavenagh J . Preclinical evaluation of the proteasome inhibitor bortezomib in cancer therapy. Cancer Cell Int 2005; 5: 1–9.

    Article  Google Scholar 

  3. Pulford K, Morris SW, Turturro F . Anaplastic lymphoma kinase proteins in growth control and cancer. J Cell Physiol 2004; 199: 330–358.

    Article  CAS  Google Scholar 

  4. Zheng B, Georgakis GV, Li Y, Bharti A, McConkey D, Aggarwal B B et al. Induction of cell cycle arrest and apoptosis by the proteasome inhibitor PS-341 in Hodgkin disease cell lines is independent of inhibitor of nuclear factor-kappaB mutations or activation of the CD30, CD40, and RANK receptors. Clin Cancer Res 2004; 10: 3207–3215.

    Article  CAS  Google Scholar 

  5. Gu T-L, Tothova Z, Scheijen B, Griffin JD, Gilliland DG, Sternberg DW . NPM-ALK fusion kinase of anaplastic large-cell lymphoma regulates survival and proliferative signaling through modulation of FOXO3a. Blood 2004; 103: 4622–4629.

    Article  CAS  Google Scholar 

  6. Ricci JE, Gottlieb RA, Green DR . Caspase-mediated loss of mitochondrial function and generation of reactive oxygen species during apoptosis. J Cell Biol 2003; 160: 65–75.

    Article  CAS  Google Scholar 

  7. Rust R, Harms G, Blokzijl T, Boot M, Diepstra A, Kluiver J et al. High expression of Mcl-1 in ALK positive and negative anaplastic large cell lymphoma. J Clin Pathol 2005; 58: 520–524.

    Article  CAS  Google Scholar 

  8. Nencioni A, Hua F, Dillon CP, Yokoo R, Scheiermann C, Cardone MH et al. Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis. Blood 2005; 105: 3255–3262.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors thank Millenniium Pharmaceutical Inc., Cambridge, MA, USA, for the kind gift of bortezomib; S Disarò, Department of Pediatrics, University of Padova, for the flow cytometry analysis. This research was supported by Fondazione Città della Speranza and by MIUR (Ministero Istruzione Università e Ricerca). PB is supported by IOV (Istituto Oncologico Veneto).

Author information

Authors and Affiliations

  1. Hematology and Oncology Clinic of Pediatrics, Azienda Ospedaliera-University of Padova, Padova, Italy

    P Bonvini, E Zorzi, G Basso & A Rosolen

Authors
  1. P Bonvini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E Zorzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G Basso
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A Rosolen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P Bonvini.

Additional information

Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu)

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bonvini, P., Zorzi, E., Basso, G. et al. Bortezomib-mediated 26S proteasome inhibition causes cell-cycle arrest and induces apoptosis in CD-30+ anaplastic large cell lymphoma. Leukemia 21, 838–842 (2007). https://doi.org/10.1038/sj.leu.2404528

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404528

This article is cited by

Search

Advanced search

Quick links